ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has initiated a clinical study of the Prodigy ™ neurostimulator, the first spinal cord stimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback